The beneficial impact of ASGR1 haploinsufficiency in protecting against CAD was first documented through a large-scale GWAS analysis in Icelanders21 and then confirmed in the UK-Biobank and the CARDIoGRAMplusC4D with three novel identified ASGR1 variants46. Here, ASGR1 is linked to coronary artery disorder.